Stanley Cohen
PhD
Professor Emeritus
👥Biography 个人简介
Stanley Cohen shared the 1986 Nobel Prize for discovering epidermal growth factor (EGF) and its receptor (EGFR). This foundational discovery launched the entire field of growth factor signaling in cancer, as EGFR became one of the most important targets in oncology — with drugs like cetuximab, gefitinib, erlotinib, and osimertinib directly targeting the EGF signaling axis across multiple cancer types.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Stanley Cohen 的研究动态
Follow Stanley Cohen's research updates
留下邮箱，当我们发布与 Stanley Cohen（Vanderbilt University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment